Viewing Study NCT07280858


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2025-12-28 @ 12:08 AM
Study NCT ID: NCT07280858
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-12
First Post: 2025-11-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.
Sponsor: SK Bioscience Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module